X0306 4 2020-03-18 false 0001410098 CorMedix Inc. CRMD 0001686223 Baluch Khoso C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS NJ 07922 true true false false Chief Executive Officer Common Stock 2020-03-18 4 P false 3500.0000 2.6100 A 56075.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 100630.0000 100630.0000 D Stock Option (Right to Buy Common Stock) 6.8200 2029-09-26 Common Stock 120000.0000 120000.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 69600.0000 69600.0000 D Stock Option (Right to Buy Common Stock) 12.6000 2026-09-30 Common Stock 250000.0000 250000.0000 D Stock Option (Right to Buy Common Stock) 12.6000 2026-09-30 Common Stock 60000.0000 60000.0000 D These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. The options will vest over four (4) years in four (4) equal annual installments on the first four (4) anniversaries of September 26, 2019, provided, in all cases, that Executive remains an employee of, or a consultant to, the Company through the applicable vesting date. These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 7,000 shares that are subject to vesting each on January 10, 2021 and January 10, 2022. These options were granted 9/30/2016. The option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020. These options were granted 9/30/2016. The option vests based on certain performance milestones. If such milestones are met prior to 12/31/18, then the option will not vest until 12/31/18. The option will be forfeited if such milestones are not met by 10/3/2020. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Khoso Baluch 2020-03-18